2025 fourth_quarter Filing
Q4Income
$60K
Filed
January 19, 2026
Lobbying Activities (2)
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATE
Lobbyists (2)
MEGAN SUSSMAN HERBER
Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA) 2014-2018
mr ELLIOT VICE
Staff Assistant, Legislative Correspondent & Scheduler, Sen. Evan Bayh (D-IN) 2009-2010